Inflammatory Prostatitis Plus IBS-D Subtype and Correlation with Immunomodulating Agent Imbalance in Seminal Plasma: Novel Combined Treatment
We recently demonstrated the effectiveness of long-term treatment with rifaximin and the probiotic DSF (De Simone formulation) in improving urogenital and gastrointestinal symptoms in patients with both chronic inflammatory prostatitis (IIIa prostatitis) and diarrhea-predominant irritable bowel synd...
Saved in:
| Main Authors: | Roberto Castiglione, Gaetano Bertino, Beatrice Ornella Vicari, Agostino Rizzotto, Giuseppe Sidoti, Placido D’Agati, Michele Salemi, Giulia Malaguarnera, Enzo Vicari |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Diseases |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-9721/12/10/260 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular characterization of autosomal recessive Glycogen storage disease type Ib in a Pakistani family
by: Zeeshan Nazir, et al.
Published: (2025-03-01) -
Mucoprotectants and gut barrier: mechanisms of action and clinical applications in IBS. Is there a possible role?
by: Francesco Rettura, et al.
Published: (2025-05-01) -
Cross‐Cohort Gut Microbiome Signatures of Irritable Bowel Syndrome Presentation and Treatment
by: Junhui Li, et al.
Published: (2024-11-01) -
Isolation and Identification of the Types of Bacteria that Cause Irritable Bowel Syndrome
by: Noor Mahmood Sultan, et al.
Published: (2025-01-01) -
Sodium butyrate in Irritable Bowel Syndrome
by: Aleksandra Kołodziej, et al.
Published: (2025-06-01)